Aliment Pharmacol Ther

1. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
   Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Aug 28. doi: 10.1111/apt.70290.
   

   >> Share

   
   
2. RANJAN MK, Vuyyuru SK
   Editorial: Corticosteroid Responsive Acute Severe Ulcerative Colitis-Revisiting Maintenance Approaches in the Era of Advanced Therapies.
   Aliment Pharmacol Ther. 2025 Aug 26. doi: 10.1111/apt.70288.
   

   >> Share

   
   

   
   Am J Gastroenterol

3. ANDRE M, Kirchgesner J, Laharie D, Guillo L, et al
   Sub-cutaneous infliximab for perianal Crohn's disease: the BioLap-Rem multicentre study from the GETAID.
   Am J Gastroenterol. 2025 Aug 28. doi: 10.14309/ajg.0000000000003755.
   

   >> Share

   
   
4. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
   Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
   Am J Gastroenterol. 2025 Aug 27. doi: 10.14309/ajg.0000000000003651.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. KAUR S, Jindal N, Kaur A, Chatterjee A, et al
   A randomized control trial to assess the effectiveness of a brief educational intervention on colonoscopy preparation and experience in patients with inflammatory bowel disease.
   BMC Gastroenterol. 2025;25:625.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

6. CARON B, Jairath V, Sands BE, Rubin DT, et al
   International Magnetic Resonance Imaging Consensus for use in Luminal Crohn's Disease Trials and Clinical Practice.
   Clin Gastroenterol Hepatol. 2025 Aug 27:S1542-3565(25)00739.
   

   >> Share

   
   
7. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
   Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
   Clin Gastroenterol Hepatol. 2025 Aug 6:S1542-3565(25)00322.
   

   >> Share

   
   

   
   Gut

8. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
   Global consensus statement on the management of pregnancy in inflammatory bowel disease.
   Gut. 2025 Aug 28:gutjnl-2025-336402. doi: 10.1136/gutjnl-2025-336402.
   

   >> Share

   
   

   
   Inflamm Bowel Dis

9. TAL N, Baram L, Gehlhaar A, Gu W, et al
   RELA Haploinsufficiency Manifesting as an Atypical Phenotype of Crohn's Disease.
   Inflamm Bowel Dis. 2025 Aug 28:izaf159. doi: 10.1093.
   

   >> Share

   
   
10. MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
    Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Aug 28:izaf171. doi: 10.1093.
    

    >> Share

    
    
11. DEISSOVA T, Al Tukmachi D, Radova L, Bohosova J, et al
    Tissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naive Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Aug 26:izaf120. doi: 10.1093.
    

    >> Share

    
    
12. GEEGANAGE G, Gade A, Saraga A, Deyhim T, et al
    Long-term Outcomes of Patients with Crohn's Disease Treated with Risankizumab.
    Inflamm Bowel Dis. 2025 Aug 26:izaf162. doi: 10.1093.
    

    >> Share

    
    

    
    PLoS One

13. KUZDAS-SALLABERGER M, Steininger B, Stohr D, Mustak-Blagusz M, et al
    Changes in patient-reported outcomes (PROs) and fecal calprotectin levels in patients with inflammatory bowel disease following a three-week gastrointestinal inpatient rehabilitation.
    PLoS One. 2025;20:e0330922.
    

    >> Share

    
    
14. DEMERS K, Hendrix EMB, Ardabili AR, Bredero QM, et al
    Lifestyle and psychosocial factors in inflammatory bowel disease: Prevalence, impact, motivation, and support needs.
    PLoS One. 2025;20:e0331092.
    

    >> Share

    
    
15. VERAL MA, Pickup RW, Roy M, Sanderson J, et al
    Geographic distribution of inflammatory bowel disease in the UK: A spatially explicit survey.
    PLoS One. 2025;20:e0329317.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share